Pharmacokinetics and 180-day safety of diazepam nasal spray in pediatric patients with epilepsy aged 2-5 years.
Saved in:
| Title: | Pharmacokinetics and 180-day safety of diazepam nasal spray in pediatric patients with epilepsy aged 2-5 years. |
|---|---|
| Authors: | Segal EB; Hackensack University Medical Center, Northeast Regional Epilepsy Group, and Hackensack Meridian School of Medicine, Hackensack, New Jersey, USA., Wheless JW; Le Bonheur Children's Hospital, University of Tennessee Health Science Center, Memphis, Tennessee, USA., Zafar M; Duke University School of Medicine, Durham, North Carolina, USA., Shih EK; Formerly of Neurelis, Inc., San Diego, California, USA., Ngo LY; Neurelis, Inc., San Diego, California, USA., Carrazana E; Neurelis, Inc., San Diego, California, USA.; John A. Burns School of Medicine, University of Hawaii, Honolulu, Hawaii, USA., Rabinowicz AL; Neurelis, Inc., San Diego, California, USA.; Center for Molecular Biology and Biotechnology (CMBB) in the Charles E. Schmidt Collage of Science at Florida Atlantic University, Boca Raton, Florida, USA. |
| Corporate Authors: | DIAZ.001.008 Study Group |
| Source: | Epilepsia [Epilepsia] 2025 Sep; Vol. 66 (9), pp. 3231-3241. Date of Electronic Publication: 2025 Jul 12. |
| Publication Type: | Journal Article; Clinical Trial, Phase I; Clinical Trial, Phase II |
| Journal Info: | Publisher: Blackwell Science Country of Publication: United States NLM ID: 2983306R Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1528-1167 (Electronic) Linking ISSN: 00139580 NLM ISO Abbreviation: Epilepsia Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| ISSN: | 1528-1167 |
|---|---|
| DOI: | 10.1111/epi.18473 |
